Taijyu Satoh

7PUBLICATIONS
78CO-AUTHORS
Respiratory diseasesToxicology (incl. clinical toxicology)Exercise physiologyComputational physiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 20, 2026
Prognostic Impact of Elevated Pulmonary Vascular Resistance in Group 2 Pulmonary Hypertension: Insights From a Japanese Multicenter Registry.

Taijyu Satoh, Koichiro Sugimura, Yoshihiro Fukumoto

|Jan 22, 2026
Pathogenesis of Pulmonary Artery Remodeling: TGF-Beta Signaling and Inhibin Subunit Beta A in Group 1 and 2 Pulmonary Hypertension.

Yusuke Yamada, Taijyu Satoh, Nobuhiro Yaoita

|Jun 26, 2025
Hypopituitarism Induced by Continuous Infusion of PGI2 Analogues: A Case Series and the Role of ACTH Screening and Hydrocortisone Treatment.

Taijyu Satoh, Yuichi Tamura, Noriaki Takama

|Dec 16, 2024
Impact of Sodium-Glucose Co-Transporter-2 Inhibitors on Exercise-Induced Pulmonary Hypertension.

Taijyu Satoh, Nobuhiro Yaoita, Satoshi Higuchi

|Jan 10, 2024
Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension.

Yi-Yin Tai, Qiujun Yu, Ying Tang

|Sep 30, 2023
Inhaled nitric oxide testing in predicting prognosis in pulmonary hypertension due to left-sided heart diseases.

Taijyu Satoh, Nobuhiro Yaoita, Kotaro Nochioka

Pageof 2

Frequent Collaborators

2 joint publications

Gil Speyer

2 joint publications

Yi-Yin Tai

2 joint publications

Stephanie Torrino

2 joint publications

Stephen Y Chan